Avivir receives the first unlimited certificate of registration for rapid antigen tests for COVID-19 in Russia

Avivir receives the first unlimited certificate of registration for rapid antigen tests for COVID-19 in Russia

07/29/2021

Avivir receives the first unlimited certificate of registration for rapid antigen tests for COVID-19 in Russia

Use of the innovative Korean-made BIOCREDIT COVID-19 Ag testing system was approved by Roszdravnadzor in July 2020. These tests can detect the virus within 10 minutes, all without special equipment. Clinical and laboratory tests of the RapiGEN systems, conducted in Moscow in June, found that they achieved 96% sensitivity with 100% precision At the height of the pandemic, this greatly simplified and expanded testing procedures.

In June of this year, research by the Gamaleya National Center of Epidemiology and Microbiology showed that the RapiGEN BIOCREDIT COVID-19 Ag test was highly effective in detecting all known strains of the virus. Previously, Rospotrebnadzor compared the effectiveness of COVID-19 antigen tests to PCR testing.

To date, BIOCREDIT COVID-19 Ag rapid tests are the most effective tests available on the Russian and global markets, and make large-scale testing possible in even the most remote regions of a country. They are also the best solution for large businesses to prevent the spread of the virus among employees. Avivir’s unlimited certificate of registration assures an uninterrupted supply of tests and their availability on the Russian market.


Загрузить ещё